Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05596539

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia

Status
Recruiting
Phase
Study type
Observational
Enrollment
130 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess medical events during follow-up of adult patients having hypophosphatasia and consulting rheumatologists.

Detailed description

Hypophosphatasia (HPP) is a rare inherited disease caused by mutations of the ALPL gene. In adult HPP, patients may suffer from fractures, pseudofractures, fracture healing complications, osteoarthritis, chondrocalcinosis, dental diseases, muscle pain and disability, but also headache, muscle weakness, ocular disease, and other symptoms. In some cases the diagnosis is severely delayed. Moreover a number of patients having such symptoms and a low level of serum alkaline phosphatase, without gene mutation can be followed by rheumatologists with difficulties in management of bone fragility and pain. The aim of this register is to describe prospectively the medical events in adult patients having hypophosphatasia, whether or not there is a proven genetic abnormality.

Conditions

Interventions

TypeNameDescription
OTHERData collectionCollection data from diagnostic Data collected following to medical exam as part of care

Timeline

Start date
2023-03-22
Primary completion
2026-03-01
Completion
2031-03-01
First posted
2022-10-27
Last updated
2025-12-16

Locations

11 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05596539. Inclusion in this directory is not an endorsement.